An analysis of CDC data for 1999-2024 shows that patient prognosis varied by sex, age, race/ethnicity, and region.

Deliberate efforts are needed to change the situation, which hasn’t improved much since 2010, researchers say.

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of ...

Ahmed Abdelnoor and Bamba Gaye discuss rethinking global collaboration in clinical trials and the importance of resolving ...

Among patients with mitral valve prolapse (MVP) undergoing cardiovascular magnetic resonance (CMR) imaging, both female sex ...

A more comprehensive view of bleeding burden can help inform discussions between patients and doctors, a researcher says.

The findings align with the trial’s main analysis, but other studies of revascularization in CLTI have come to the opposite ...

Tirzepatide (Mounjaro; Lilly) appears to reduce major cardiovascular events beyond what can be achieved with placebo for ...

One year after the FDA's approval, Shmuel Chen and Philippe Généreux give an update on the successes and challenges in this ...

People who are subjected to both hot weather and air pollution caused by fires at the same time are at higher risk of dying ...

The findings unlock a trove of data from millions of CT scans done for lung cancer screening or other purposes, researchers ...

Kausik Ray talks with host Yael L. Maxwell about how he knew his path early but still made pivots, all the while putting patients' needs first.